Investigating the activity spectrum for Ring-Substituted 8-Hydroxyquinolines

Molecules

Volumn 15, Issue 1, 2010, Pages 288-304

  Musiol, Robert ^a   Jampilek, Josef ^b,c   Nycz, Jacek E ^a   Pesko, Matus ^d   Carroll, James ^e   Kralova, Katarina ^d   Vejsova, Marcela ^f   O'Mahony, Jim ^e   Coffey, Aidan ^e   Mrozek, Anna ^a   Polanski, Jaroslaw ^a  

^a UNIVERSITY OF SILESIA   (Poland)

^b Zentiva Prague   (Czech Republic)

^c UNIVERSITY OF VETERINARY AND PHARMACEUTICAL SCIENCES   (Czech Republic)

^d Faculty of Natural Sciences   (Slovakia)

^e Department of Chemistry   (Ireland)

^f Charles University in Prague Faculty of Pharmacy   (Czech Republic)

Author keywords

In vitro antifungal activity; In vitro antimycobacterial activity; Lipophilicity; Pet inhibition; Quinolines; Spinach chloroplasts

Indexed keywords

ANTIFUNGAL AGENT; ANTIINFECTIVE AGENT; QUINOLINOL DERIVATIVE;

ARTICLE; CANDIDA ALBICANS; CHEMISTRY; CHLOROPLAST; DRUG EFFECT; ELECTRON TRANSPORT; METABOLISM; MICROBIOLOGICAL EXAMINATION; MYCOBACTERIUM; PHOTOSYNTHESIS; SPINACH; SYNTHESIS;

ANTI-BACTERIAL AGENTS; ANTIFUNGAL AGENTS; CANDIDA ALBICANS; CHLOROPLASTS; ELECTRON TRANSPORT; HYDROXYQUINOLINES; MICROBIAL SENSITIVITY TESTS; MYCOBACTERIUM; PHOTOSYNTHESIS; SPINACIA OLERACEA;

EID: 75749094375     PISSN: None     EISSN: 14203049     Source Type: Journal    
DOI: 10.3390/molecules15010288     Document Type: Article

References (48)

1. Roth, H.J.; Fenner, H. Arzneistoffe, 3rd ed.; Deutscher Apotheker Verlag: Stuttgart, Germany, 2000; pp. 51-114.
2. Harris, C.R.; Thorarensen, A. Advances in the discovery of novel antibacterial agents during the year 2002. Curr. Med. Chem. 2004, 11, 2213-2243.
3. Andries, K.; Verhasselt, P.; Guillemont, J.; Gohlmann, H.W.; Neefs, J.M.; Winkler, H.; van Gestel, J.; Timmerman, P.; Zhu, M.; Lee, E.; Williams, P.; de Chaffoy, D.; Huitric, E.; Hoffner, S.; Cambau, E.; Truffot-Pernot, C.; Lounis, N.; Jarlier, V. A diarylquinoline drug active on the ATP synthase of Mycobacterium tuberculosis. Science 2005, 307, 223-227.
4. 4. Vangapandu, S.; Jain, M.; Jain, R.; Kaur, S.; Singh, P.P. Ring-substituted quinolines as potential anti-tuberculosis agents. Bioorg. Med. Chem. 2004, 12, 2501-2508. (Pubitemid 38542774)
5. 5. Carta, A.; Piras, S.; Palomba, M.; Jabes, D.; Molicotti, P.; Zanetti, S. Anti-mycobacterial activity of quino Iones. Triazoloquinolones a new class of potent anti-mycobacterial agents. Anti-Infective Agents Med. Chem. 2008, 7, 134-147. (Pubitemid 351761452)
6. 6. Sissi, C.; Palumbo, M. The quinolone family: From antibacterial to anticancer agents. Curr. Med. Chem. Anti-Cane. Agents 2003, 3, 439-450. (Pubitemid 37236414)
7. 4 as marker of 5-LO inhibitory activity of two new N-ethoxycarbonyl-4-quinolones. Pharm. Biomed. Anal. 1999, 19, 539-549.
8. 8. Ko, T.C.; Hour, M.J.; Lien, J.C; Teng, C.M.; Lee, K.H.; Kuo, S.C.; Huang, L.J. Synthesis of 4-alkoxy-2-phenylquinoline derivatives as potent antiplatelet agents. Bioorg. Med. Chem. Lett. 2001, 11, 279-282. (Pubitemid 32115829)
9. 9. Jampilek, J.; Dolezal, M.; Kunes, J.; Vichova, P.; Jun, D.; Raich, I.; O'Connor, R.; Clynes, M. Synthesis of (2E)-2-methyl-3-(4-{[4-(quinolin-2- ylmethoxy)phenyl]sulfanyl}phenyl)prop-2-enoic acid (VUFB 20609) and 2-methyl-3-(4-{[4-(quinolin-2-ylmethoxy)phenyl]sulfanyl}phenyl) propionic acid (VUFB 20584) as potential antileukotrienic agents. J. Pharm. Pharmacol. 2004, 56, 783-794. (Pubitemid 38807302)
10. 10. Jampilek, J.; Dolezal, M.; Kunes, J.; Vichova, P.; Jun, D.; Raich, I.; O'Connor, R.; Clynes, M. Preparation of 2-(4-{[4-(quinolin-2-ylmethoxy) phenyl]sulfanyl}phenyl)propionic acid (VUFB 20615) and 2-methyl-2-(4-{[4- (quinolin-2-ylmethoxy)phenyl]sulfanyl}phenyl)propionic acid (VUFB 20623) as potential antileukotrienic agents. Curr. Org. Chem. 2004, 8, 1235-1243. (Pubitemid 39162407)
11. Jampilek, J.; Doležal, M.; Opletalova, V.; Haiti. J. 5-Lipoxygenase, leukotrienes biosynthesis and potential antileukotrienic agents. Curr. Med. Chem. 2006, 13, 117-126.
12. Polanski, J.; Zouhiri, F.; Jeanson, L.; Desmaele, D.; d'Angelo, J.; Mouscadet, J.F.; Gieleciak, R.; Gasteiger, J.; Le Bret. M. Use of the Kohonen neural network for rapid screening of ex vivo antiHIV activity of styrylquinolines. J. Med. Chem. 2002, 45, 4647-4654.
13. Polanski, J.; Niedbala, H.; Musiol, R.; Tabak, D.; Podeszwa, B.; Gieleciak, R.; Bak, A.; Palka, A.; Magdziarz, T. Analogues of styrylquinoline and styrylquinazoline HIV-1 integrase inhibitors: Design and synthetic problems. Acta Poloniae Pharm. Drug Res. 2004, 61, 3-4.
14. Polanski, J.; Niedbala, H.; Musiol, R.; Podeszwa, B.; Tabak, D.; Palka, A.; Meneei, A.; Finster, J.; Mouscadet, J.F.; Le Bret, M. 5-Hydroxy-8-nitro-6- quinaldic acid as a novel molecular scaffold for HIV-I integrase inhibitors. Lett. Drugs Des. Disc. 2006, 3, 175-178.
15. 15. Polanski, J.; Niedbala, H.; Musiol, R.; Podeszwa, B.; Tabak, D.; Palka, A.; Meneei, A.; Mouscadet, J.F.; Le Bret, M. Fragment based approach for the investigation of HIV-1 integrase inhibition. Lett. Drugs Des. Disc. 2007, 4, 99-105. (Pubitemid 46121455)
16. 16. Vargas, L.Y.; Castelli, M.V.; Kouznetsov, V.V.; Urbina, J.M.; Lopez, S.N.; Sortino, M.; Enriz, R.D.; Ribas, J.C.; Zacchino, S. In vitro antifungal activity of new series of homoallylamines and related compounds with inhibitory properties of the synthesis of fungal cell wall polymers. Bioorg. Med. Chem. 2003, 11, 1531-1550. (Pubitemid 36293545)
17. Jampilek, J.; Dolezal, M.; Kunes, J.; Buchta, V.; Kralova, K. Quinaldine Derivatives: Preparation and Biological Activity. Med. Chem. 2005, 1, 591-599.
18. Musiol, R.; Jampilek, J.; Buchta, V.; Niedbala, H.; Podeszwa, B.; Palka, A.; Majerz-Maniecka, K.; Oleksyn, B.; Polanski, J. Antifungal properties of new series of quinoline derivatives. Bioorg. Med. Chem. 2006, 14, 3592-3598.
19. 19. Musiol, R.; Jampilek, J.; Králova, K.; Richardson, D.R.; Kalinowski, D.; Podeszwa, B.; Finster, J.; Niedbala, H.; Palka, A.; Polanski, J. Investigating biological activity spectrum for novel quinoline analogues. Bioorg. Med. Chem. 2007, 15, 1280-1288. (Pubitemid 46038140)
20. Musiol, R.; Tabak, D.; Niedbala, H.; Podeszwa, B.; Jampilek, J.; Králova, K.; Dohnal, J.; Finster, J.; Mencel, A.; Polanski, J. Investigating biological activity spectrum for novel quinoline analogues 2: Hydroxyquinolinecarboxamides with photosynthesis inhibiting activity. Bioorg. Med. Chem. 2008, 16, 4490-4499.
21. Jampilek, J.; Musiol, R.; Pesko, M.; Kralova, K.; Vejsova, M.; Carroll, J.; Coffey, A.; Finster, J.; Tabak, D.; Niedbala, H.; Kozik, V.; Polanski, J.; Csollei, J.; Dohnal, J. Ring-substituted 4-hydroxy-lH-quinolin-2-ones: Preparation and biological activity. Molecules 2009, 14, 1145-1159.
22. Jampilek, J.; Musiol, R.; Finster, J.; Pesko, M.; Carroll, J.; Kralova, K.; Vejsova, M.; O'Mahony, J.; Coffey, A.; Dohnal, J.; Polanski, J. Investigating biological activity spectrum for novel styrylquinazoline analogues. Molecules 2009, 14, 4246-4265.
23. Podeszwa, B.; Niedbala, H.; Polanski, J.; Musiol, R.; Tabak, D.; Finster, J.; Serafin, K.; Wietrzyk, J.; Boryczka, S.; Mol, W.; Jampilek, J.; Dohnal, J.; Kalinowski, D.; Richardson, D.R. Investigating the antiproliferative activity of quinoline-5,8-dione analogues on tumour cell lines. Bioorg. Med. Chem. Lett. 2007, 17, 6138-6141.
24. WHO Report 2008. Global Tuberculosis Control - Surveillance, Planning, Financing; http://www.who.in/tb/publications/global-report/2008/summary/en/ index.html/, accessed on 28 October 2009.
25. Field, S.K.; Cowie, R.L. Lung disease due to the more common nontuberculous mycobacteria. Chest 2006, 129, 1653-1672.
26. Wagner, D.; Young, L.S. Nontuberculous mycobacterial infections: A clinical review. Infection 2004, 32, 257-270.
27. Morrone, N.; Cruvinel, M.C.; Morrone, N., Jr.; Freire, J.A.; Oliveira, L.M.; Goncalves, C. Pneumopatia causada por Mycobacterium kansasii. J. Pneumol. 2003, 29, 341-349.
28. Doctor Fungus; http://www.doctorfungus.org/, accessed on 28 October 2009.
29. Gershon, H; Gershon, M; Clarke, D.D. Synergistic mixtures of fungitoxic monochloro- and dichloro-8-quinolinols against five fungi. Mycopathologia 2004, 158, 131-135.
30. 30. Dardari, Z.; Lemrani, M.; Bahloul, A.; Sebban, A.; Hassar, M.; Kitane, S.; Berrada, M.; Boudouma, M. Antileishmanial activity of a new 8-hydroxyquinoline derivative designed 7-[5′-(3′-phenylisoxazolino) methyl]-8-hydroxyquinoline: Preliminary study. Farmaco 2004, 59, 195-199. (Pubitemid 38251616)
31. Draber, W.; Tietjen, K.; Kluth, J.F.; Trebst, A. Herbicides in photosynthesis research. Angew. Chem. Int. Ed. Engl. 1991, 3, 1621-1633.
32. 32.Tischer,W.;Strotmann,H. Relationshipbetweeninhibitorbindingbychloroplastsandinhibitionof photosyntheticelectrontransport.Biochim.Biophys.Acta1977,460,113-125. (Pubitemid8067010)
33. Trebst, A.; Draber, W. Structure activity correlations of recent hrbicides in photosynthetic reactions. In Advances in Pesticide Science, Greissbuehler, H., Ed.; Pergamon Press: Oxford, UK, 1979; pp. 223-234.
34. Bowyer, J.R.; Camilleri, P.; Vermaas, W.F.J. In Herbicides, Topics in Photosynthesis. Baker, N.R., Percival, M.P., Eds.; Elsevier: Amsterdam, The Netherlands, 1991; Volume 10. pp. 27-85.
35. Kralova, K.; Sersen, F.; Kubicova, L.; Waisser, K. Inhibition of photosynthetic electron transport in spinach chloroplasts by 3-and 4-halogeno substituted benzanilides and thiobenzanilides. J. Trace Microprobe Techn. 2000, 18, 251-256.
36. Kralova, K.; Sersen, F.; Miletín, M., Dolezal, M. Inhibitory effects of substituted benzanilides on photosynthetic electron transport in spinach chloroplasts. Chem. Pap. 2002, 56, 214-217.
37. Dolezal, M.; Palek, L.; Vinsova, J.; Buchta, V.; Jampilek, J.; Kralova, K. Substituted pyrazinecarboxamides: Synthesis and biological evaluation. Molecules 2006, 11, 242-256.
38. Kerns, E.H.; Li, D. Drug-Like Properties; Concept, Structure Design and Methods; Elsevier: San Diego, CA, USA, 2008.
39. Honda, I.; Yoneyama, K.; Iwamura, H.; Konnai, M.; Takahashi, N.; Yoshida, S. Structure-activity relationship of 3-nitro-2,4,6-tri-hydroxybenzamide derivatives in photosynthetic electron transport inhibition. Agric. Biol. Chem. 1990, 54, 1227-1233.
40. Messinger, P.; Meyer, H. The reaction of iodohydroxyquinolinesulfonic acid with nitrite. Arch. Pharm. 1976, 309, 1009-1010.
41. Ponikiewski, L.; Nycz, J.E. 3-[(E)-2-(5,7-Dichloro-8-hydroxyquinolin-2- yl)vinyl]-4hydroxyphenyl acetate. Acta Cryst. E 2009, 65, 515.
42. Nycz, J.E.; Ponikiewski, L. Unpublished data, 2009. Detailed analysis of the structure of these compounds will be published elsewhere.
43. Sheehan, D.J.; Espinel-Ingroff, A.; Steele, M.; Webb, C.D. Antifungal susceptibility testing of yeasts: Abrief overview. Clin. Infect. Dis. 1993, 17, 494-500.
44. National Committee for Clinical Laboratory Standards. Reference Method for Broth Dilution Testing of Yeasts: Approved Standard M27-A2, 2nd ed.; National Committee for Clinical Laboratory Standards: Wayne, PA, USA, 2002.
45. National Committee for Clinical Laboratory Standards. Method for Antifungal Disk Diffusion Susceptibility Testing of Yeasts: Approved Guideline M44-A; National Committee for Clinical Laboratory Standards: Wayne, PA, USA, 2004.
46. Masarovicova, E.; Kralova, K. Approaches to measuring plant photosynthesis activity. In Handbook of Photosynthesis, 2nd ed.; Pessarakli, M., Ed.; Taylor & Francis Group: Boca Raton, London/New York/Singapore, 2005; pp. 617-656.
47. Kralova, K.; Sersen, F.; Sidoova, E. Photosynthesis inhibition produced by 2-alkylthio-6-Rbenzothiazoles. Chem. Pap. 1992, 46, 348-350.
48. Fedke, C. Biochemistry and Physiology of Herbicide Action; Springer Verlag: Berlin, Germany, 1982.